Report Categories
View AllRecent Articles
View All
Prologis Inc PLD Posts Robust Q1 2026 FFO and Revenue Beats Driven by Resilient Industrial Leasing Demand
How Toll Brothers TOL revenue breaks down and what it means Investor Concern 20260511
JDcom Inc JD Proposed Ceconomy Acquisition Faces EU Regulatory Review Over Foreign Subsidy Concerns
Zeo Energy ZEO Stock Closes Position Breakout Watch 20260420
Magnolia MGY Stock Daily Review 123 20260420
BLTE Belite Bio misses Q4 earnings estimates by 256 percent posts zero revenue shares dip slightly
LINE Lineage Q4 2025 earnings deliver strong upside surprise stock notches modest gains on positive investor reaction
Bitdeer BTDR Stock ShortTerm Trend Analysis Q4 2025 EPS Exceeds Expectations
How Nuveen JGH manages counterparty exposure
Dhanuka Agritech Announces 70 Crore Share Buyback and 2 Dividend Record Date Set
Intrum Stock Gains After UBS Upgrade Highlights Capital Raise Progress
The Simply SMPL Climbs 242 Resistance at 1242 in Focus 20260518
Viemed VMD Rallies 310 as Bulls Target 1012 20260518
Chinas Humanoid Robot Workforce Race Competition for Teslas Optimus
Woodside WDS Q4 2025 Earnings Why the Beat Matters
Fate Therapeutics FATE Climbs 1168 Resistance at 216 in Focus 20260521
Lyell Immunopharma LYEL Surges 676 Nearing 1808 Resistance 20260520
NBHC Q1 2026 Earnings EPS Misses Estimates Stock Edges Higher
GitLab Q1 2026 Earnings EPS Beat Drives Stock Uptick
Central Garden Pet CENT Q1 2026 Earnings Strong EPS Beat of 154 Drives Modest Stock Gains
NewAmsterdam Pharma NAMS Q1 2026 Earnings EPS Beat Reflects Cost Management Amid PreRevenue Phase
Cavco Industries Q1 2026 Earnings EPS Beats Estimates by 102 Stock Rises 36
ZOOZ Strategy Ltd Breaks Out 86 Approaches Key Resistance at 032
Precigen Inc PGEN Tests Key Support as Bearish Pressure Persists Near 403
HubSpot HUBS Edges Higher as Investors Eye Key Resistance Level
Stoke Therapeutics STOK Sees Minor Decline as Shares Test Support Near 28 Level